Clinical trials: Operable Breast Neoplasms

Neoplasms, Breast

Letrozole In Combination With Lapatinib In Neoadjuvant Treatment Of Early Breast Cancer

• Completed
• Age: 18 to 80 years
• Phase 2
• Results posted

Evaluate the percentage of clinical objective responses (cOR) in patients with HER2 negative early breast cancer treated with pre operative (neoadjuvant)lapatinib and letrozole

Trial name

NCT00422903

Testing

lapatinib, letrozole

Where

14 sites in Italy, Spain

Volunteers

92 people

Sponsor

GlaxoSmithKline